XML 11 R4.htm IDEA: XBRL DOCUMENT v3.26.1
Condensed Consolidated Statements of Comprehensive Loss - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Operating expenses:        
Research and development $ 15,152 $ 9,389 $ 25,093 $ 17,200
General and administrative 5,357 4,333 10,328 7,992
Total operating expenses 20,509 13,722 35,421 25,192
Loss from operations (20,509) (13,722) (35,421) (25,192)
Other income (expense):        
Interest income, net 2,696 1,407 4,392 2,532
Other (expense) income, net (3) (7) 1 (13)
Total other income, net 2,693 1,400 4,393 2,519
Loss before income taxes (17,816) (12,322) (31,028) (22,673)
Income tax benefit (19) (21) (39) (32)
Net loss $ (17,797) $ (12,301) $ (30,989) $ (22,641)
Basic net loss per common share outstanding $ (0.11) $ (0.09) $ (0.21) $ (0.18)
Diluted net loss per common share outstanding $ (0.11) $ (0.09) $ (0.21) $ (0.18)
Weighted average shares of common stock used in net loss per share attributable to common stockholders, basic 156,602,158 130,350,391 151,127,942 124,015,763
Weighted average shares of common stock used in net loss per share attributable to common stockholders, diluted 156,602,158 130,350,391 151,127,942 124,015,763
Net loss $ (17,797) $ (12,301) $ (30,989) $ (22,641)
Other comprehensive loss:        
Net unrealized losses on available-for-sale marketable securities (235) (49) (573) (37)
Comprehensive loss $ (18,032) $ (12,350) $ (31,562) $ (22,678)